Pearls and Prep

MDD with Mixed Features: What Do You Reach for When SSRIs Stop Making Sense?

26 min · 19. maj 2026
episode MDD with Mixed Features: What Do You Reach for When SSRIs Stop Making Sense? cover

Beskrivelse

Today, we're diving into the wild world of Major Depressive Disorder with mixed features—yeah, it's as tricky as it sounds! We’re chatting about how this gray area in mental health can really throw a wrench in the works for both patients and clinicians. Did you know that around one in five folks with MDD has these mixed features? That's a number that gets my attention! We're breaking down the challenges, like figuring out if a patient’s racing thoughts are part of their depression or something else entirely. Plus, we're throwing in some insights on how to handle these cases without making things worse—because let's face it, nobody wants to be the one who accidentally triggers a manic episode. So grab your favorite snack, kick back, and let’s get into the nitty-gritty of managing MDD with mixed features! 32 MDD with Mixed Features: What Do You Reach for When SSRIs Stop Making Sense? Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink Diving into the deep end of mental health, we tackle the slippery slope of Major Depressive Disorder with mixed features. You know, that tricky little beast that makes diagnosing a real head-scratcher. We’re talking about a patient, let’s call her Polly (MOCK PATIENT) who’s juggling depression with some manic symptoms. Picture this: she's on Zoloft, feeling more wired than a kid on Halloween candy, and yet, the gloom still lingers. So, what gives? We explore the nuances of mixed features that can masquerade as just plain old depression. I'll share some insight on the DSM-5 criteria that helps differentiate between the two, and trust me, it’s not as simple as it sounds. The episode really shines a light on the importance of careful diagnosis. We don't want to end up treating Polly’s depression while inadvertently sending her spiraling into mania. It’s a balancing act, folks! And then, we dive into treatment strategies, highlighting Latuda — the not-so-secret weapon in our pharmacological arsenal. This medication has shown some pretty impressive results in clinical trials for mixed features, and we unpack why it's a solid choice to avoid the pitfalls of traditional SSRIs. Let’s just say, we’re not about to throw Polly to the wolves without a proper plan! Get ready for a wild ride through the gray areas of mental health as we unravel the complexities of mixed features in Major Depressive Disorder. We kick things off by introducing a patient named Polly, who’s caught in a whirlwind of depression and those pesky manic symptoms. I mean, how do you treat someone who’s feeling low but also has moments of racing thoughts and irritability? It’s like trying to solve a Rubik's Cube while blindfolded! We dig into the DSM-5 criteria and some stats that reveal how common these mixed features really are. Spoiler alert: they’re more prevalent than you might think! I share some clinical anecdotes and the challenges that come with diagnosing mixed features versus straightforward depression. And then we get into the nitty-gritty of treatment. Forget the one-size-fits-all approach! We chat about Latuda and its role in stabilizing mood without triggering a manic episode. It’s all about finding that sweet spot and ensuring our patients get the care they need. This isn’t just a lecture; it’s a practical chat that aims to turn you from a good clinician into a great one! Strap in for a rollercoaster of insights on the often-murky waters of Major Depressive Disorder with mixed features. We’re going to meet Polly, our case study for the day, who’s navigating the complexities of mood disorders like a pro, but without the right treatment, she might just be left in the lurch. The episode kicks off with an exploration of the DSM-5 criteria for diagnosing mixed features and how it’s a game-changer in treatment planning. We’ll dissect Polly’s symptoms and figure out why she’s still feeling down despite being on Zoloft. Is it time to switch gears and consider a different approach? We walk through the potential dangers of SSRIs in patients with mixed features and why they might not be the best bet. Enter Latuda — our hero of the day! We’ll break down the science behind how it works, why it’s effective, and how it can help stabilize those mixed symptoms without sending patients into hyperdrive. Plus, you’ll get tips on how to support your patients better and ensure they aren’t just another statistic in the mental health world. This episode is packed with practical advice and a sprinkle of humor to keep things light while we tackle serious topics. Takeaways: * In outpatient practice, major depressive disorder with mixed features is super common and tricky to spot. * About 1 in 5 patients with major depressive disorder has mixed features, which can complicate treatment. * When treating MDD with mixed features, SSRIs can be risky as they may trigger manic episodes. * Latuda is a promising option for MDD with mixed features, showing significant efficacy in studies. Companies mentioned in this episode: * Zoloft * Latuda * Vralar This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

Kommentarer

0

Vær den første til at kommentere

Tilmeld dig nu og bliv en del af Pearls and Prep-fællesskabet!

Kom i gang

1 måned kun 9 kr.

Derefter 99 kr. / måned · Opsig når som helst.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

Alle episoder

84 episoder

episode What If Your Most Stable Patient Is Developing Your Biggest Blind Spot? cover

What If Your Most Stable Patient Is Developing Your Biggest Blind Spot?

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep [https://www.patreon.com/PearlsandPrep] We're diving into tardive dyskinesia today, and trust me, this is something you definitely want to know about. We’re breaking down what it is, how to spot it, and what to do if you find it hanging around. By the end of our chat, you’ll be so pumped with knowledge you might just turn into a walking medical exam! We’ve got some juicy pearls to share that’ll help you navigate this tricky topic like a pro. So, grab your favorite snack and let's get into it, ‘cause this episode is packed with insights that’ll keep you sharp in practice! 32 What If Your Most Stable Patient Is Developing Your Biggest Blind Spot? Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink Tardive dyskinesia is the name of the game today, and trust me, it's a big deal. We dive deep into this movement disorder, which is basically a party crasher brought on by certain meds like Haldol. Picture this: Joe, our fictional patient, walks in with some serious lip smacking and tongue darting moves that even he doesn’t notice, but his wife Rosa? She's worried. We break down how to recognize tardive dyskinesia, the tricky business of treating it without making things worse, and why simply lowering the dose isn’t always the fix we think it is. By the end of our chat, you’ll be ready to do an AIMS exam on anyone who crosses your path—seriously, you’ll be that empowered! Plus, we sprinkle in some practical tips on how to manage these symptoms, keeping Joe’s medication intact without sending him spiraling back into psychosis. So grab a seat, kick back, and let’s get into the nitty-gritty of keeping our patients safe while navigating the wild world of psychiatry. Takeaways: * Tardive dyskinesia is a movement disorder caused by long-term use of antipsychotics, particularly Haldol. * It's super important to monitor patients on antipsychotics for tardive dyskinesia regularly to catch it early. * Lowering or stopping antipsychotics can make tardive dyskinesia worse, so be careful with that. * VMAT2 inhibitors can help manage tardive dyskinesia without compromising antipsychotic effectiveness. * Doing an Ames exam is crucial for identifying tardive dyskinesia in patients, so don’t skip it! * Second-generation antipsychotics can also cause tardive dyskinesia, even if they seem less risky. Links referenced in this episode: * patreon.com/pearlsandprep [https://patreon.com/pearlsandprep] Companies mentioned in this episode: * Haldol * Prozac * Zoloft * Adderall * Risperdal * Olanzapine * Zyprexa * Abilify * Seroquel * clozapine This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

I går24 min
episode Tardive Dyskinesia Risk Factors: One of These Should Jump Off the Page cover

Tardive Dyskinesia Risk Factors: One of These Should Jump Off the Page

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep [https://www.patreon.com/PearlsandPrep] We're diving into the world of tardive dyskinesia today, and let me tell ya, it's a biggie! We're breaking down the nitty-gritty of assessing risk and figuring out who’s most at risk for these pesky movements. Think of tardive dyskinesia as that friend who shows up late and makes a scene—totally not cool, right? We’re throwing some scenarios your way to test your skills on picking the highest risk patient. Spoiler alert: age is the real MVP when it comes to risk factors, so stick around as we unravel this mystery and arm you with the knowledge to kick some serious butt in your practice! 32 Tardive Dyskinesia Risk Factors: One of These Should Jump Off the Page Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink Get ready to dive deep into the world of tardive dyskinesia, my friends! This episode kicks off with a warm welcome and straight into the meat of the matter. We’re tackling the complexities of assessing risk related to tardive dyskinesia, and trust me, it’s a ride. The host brilliantly breaks down the term itself, drawing from ancient Greek to make it stick in our minds. Picture this: tardive means ‘late,’ and dyskinesia refers to ‘abnormal movement.’ With some cheeky humor about tardy friends and the challenges they present, we’re not just learning; we’re also chuckling along the way. As we get into the nitty-gritty, we’re faced with a thought-provoking board bomb challenge where we have to figure out which patient is at the highest risk for developing tardive dyskinesia among a group of five. This isn’t just a walk in the park; it’s a real brain-teaser! Each patient has a unique profile, and we learn how age, medications, and duration of treatment play a crucial role in the risk factors. The host emphasizes that age is the single greatest risk factor, which might surprise some listeners, especially since many don’t associate tardive dyskinesia with older adults on antidepressants. So, buckle up as we navigate through the dos and don’ts of psychiatric medications and how they relate to this condition, all while maintaining a lighthearted vibe and engaging commentary. By the end of the episode, we’re not just walking away with knowledge; we’re armed with pearls of wisdom about how to monitor and advocate for patients at risk of tardive dyskinesia. Expect to be empowered with practical tips on using the Abnormal Involuntary Movement Scale (AIMS) and a reminder that our patients need us to be their advocates. Let’s just say, this episode is both enlightening and fun, making it a must-listen for anyone in the field of psychiatry! Takeaways: * Tardive dyskinesia means late abnormal movements, kinda like being fashionably late to a party. * Age is the biggest deal when it comes to developing tardive dyskinesia, so watch out for those older folks! * Antipsychotics can be tricky; knowing their doses and risks could save you a headache later. * Using the AIMS assessment tool helps you keep track of tardive dyskinesia symptoms and their severity. Links referenced in this episode: * patreon.com/pearlsandprep [https://patreon.com/pearlsandprep] Companies mentioned in this episode: * Eminem * Moby * Risperidol * Abilify * Seroquel * Clozapine * Zyprexa This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

5. juni 202615 min
episode The Benzo Boarding Pass: The Pharmacokinetics of Fear at 35,000 Feet cover

The Benzo Boarding Pass: The Pharmacokinetics of Fear at 35,000 Feet

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep [https://www.patreon.com/PearlsandPrep] We're diving into the wild world of flying phobias today, and trust me, it's a bumpy ride! Our buddy Aaron (mock patient) is sweating bullets over his upcoming 17-hour flight from New York to Sydney, and he's looking for some serious help to conquer that fear. We're gonna unpack all things psychopharmacology to figure out the best meds for him, keeping in mind the right onset and duration so he doesn’t freak out mid-air. We'll chat about the good, the bad, and the downright ugly when it comes to anxiety meds like Xanax and Klonopin. So, buckle up, because we’re about to get into the nitty-gritty of how to keep our pal calm while soaring through the clouds! 32 The Benzo Boarding Pass: The Pharmacokinetics of Fear at 35,000 Feet Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink Taking a deep dive into the world of flying phobias, this episode serves up a mix of psychopharmacology and practical advice for dealing with anxiety in the skies. We're introduced to a hypothetical patient, Aaron, who's gearing up for a marathon flight from New York to Sydney—16 hours of pure anxiety for someone terrified of flying. The conversation flows as we explore various medications and their effects, focusing on the importance of choosing the right one for Aaron's needs. Spoiler alert: Xanax is a no-go for this long haul. With a blend of humor and expert knowledge, we break down the pharmacological properties that make certain medications work better for Aaron's situation, while also keeping it real with the challenges of managing anxiety. It’s a fun, informative ride filled with insights into how to best support patients with flying phobias and the importance of understanding medication dynamics—because when you're 35,000 feet up, timing is everything! Takeaways: * This episode dives into the anxiety of flying, focusing on a patient named Aaron who has a serious phobia about air travel, which is super relatable for many of us. * We explore the importance of understanding medication onset and duration, especially when dealing with anxiety meds for long flights like Aaron's 17-hour trek from New York to Sydney. * Klonopin is highlighted as a better choice for flight anxiety due to its longer duration and slower onset, compared to other options like Xanax, which can be too quick and cause rebound anxiety. * The podcast emphasizes that while medications can help, they aren't a cure-all; understanding the patient's fear and potentially incorporating therapy is super important for long-term solutions. * Flying can be a real challenge for anxiety sufferers, and this episode provides insightful tips for managing those nerves while also keeping humor in the mix. * Remember, it's all about timing when it comes to taking these meds; knowing when they kick in can make or break a flight experience for someone like Aaron. Companies mentioned in this episode: * Xanax * Valium * Klonopin * Ativan This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

4. juni 202624 min
episode Ninjas at Costco: OCD, PTSD, GAD, or Emerging Psychosis? cover

Ninjas at Costco: OCD, PTSD, GAD, or Emerging Psychosis?

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep [https://www.patreon.com/PearlsandPrep] Today we're diving into a wild case about a guy named Dustin (mock patient) who's convinced that ninjas are lurking around, waiting to attack him if he steps outside. Sounds pretty out there, right? But it’s not just a quirky story; we’re unpacking the real-life implications of trauma and anxiety in this episode. We'll explore how Dustin's past mugging might be triggering this intense fear and look into the possibility of OCD versus a delusional disorder. So, grab your favorite snack, kick back, and let's get into the nitty-gritty of mental health diagnoses and the art of asking the right questions. Trust me, you won't want to miss this one! 32 Ninjas at Costco: OCD, PTSD, GAD, or Emerging Psychosis? Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink Dustin, our 34-year-old IT whiz, is in a bit of a pickle. He’s been stuck at home, convinced that if he steps outside, he’s going to get jumped by ninjas (yes, you heard that right, ninjas). He’s not just being dramatic; this stems from a real mugging incident that happened six months ago outside a 7-Eleven. Who knew a late-night snack run could lead to such a wild case of paranoia? We dive deep into Dustin's psyche, exploring how trauma can manifest in quirky ways, like counting to seven before entering a building or checking his car locks five times. As we dissect this case, we navigate the murky waters of potential diagnoses, from PTSD to OCD, and even ask the question: are these ninjas real in his mind or just a metaphor for his fears? It’s all about understanding the roots of his anxiety and making sense of his ninja fears while keeping it light and relatable. We all have our quirks and fears, but Dustin's take is definitely a plot twist! Takeaways: * In the clinic, we often face ambiguous cases like Dustin's, which require us to dig deeper. * Dustin's fear of ninjas reveals a complex psychological state that needs thorough exploration. * Understanding the root of a patient's fears is crucial for accurate diagnosis and effective treatment. * Careful questioning can help clarify whether a patient's beliefs are delusional or a symptom of OCD. * Dustin's counting ritual before entering buildings suggests OCD, linked to trauma from his mugging. * Recognizing the nuances between PTSD, OCD, and other disorders is key to effective patient management. This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

3. juni 202627 min
episode 6 Pearls You May Have Not Known about Major Depressive Disorder with Psychotic Features cover

6 Pearls You May Have Not Known about Major Depressive Disorder with Psychotic Features

This episode elucidates six critical pearls concerning major depressive disorder with psychotic features, emphasizing its severity and implications for treatment. The first salient point underscores that this condition represents not merely a variant of depression, but a significant clinical challenge, characterized by a markedly elevated risk of relapse, hospitalization, and mortality. As we delve deeper into the discussion, we will further differentiate between mood congruent and incongruent psychosis, and explore essential safety assessments necessary for patients exhibiting psychotic symptoms. Moreover, we will outline effective treatment strategies, including pharmacological options and considerations for ongoing management post-remission. By the conclusion of this episode, we aim to equip listeners with a nuanced understanding of this complex disorder and the imperative of tailored therapeutic approaches. 22 6 Pearls You May Have Not Known about Major Depressive Disorder with Psychotic Features Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink A thorough examination of major depressive disorder with psychotic features is undertaken, illuminating the intricacies associated with this severe mental health condition. The discussion begins with an elucidation on the concept that depression with psychotic features represents a heightened reality distortion, thereby intensifying the clinical implications for patient management. Notably, individuals experiencing this disorder exhibit a significantly elevated risk of recurrent depressive episodes and an augmented probability of hospitalization, underscoring the necessity for vigilant clinical assessment and intervention strategies. The speaker emphasizes the importance of recognizing these critical distinctions to inform treatment approaches that diverge from conventional protocols for non-psychotic depression. Furthermore, the presentation delineates the stark contrast between mood-congruent and mood-incongruent psychotic features, offering clinical practitioners a nuanced framework for diagnostic differentiation. Such distinctions are paramount, as they guide not only the diagnostic process but also the subsequent therapeutic interventions, enhancing the clinician's capacity to tailor treatment to individual patient needs, consequently leading to improved outcomes. Takeaways: * The first pearl discussed emphasizes that major depressive disorder with psychotic features is significantly more severe, increasing risks of relapse, hospitalization, and mortality. * It is crucial to differentiate between mood congruent and mood incongruent psychosis, as this distinction aids in accurate diagnosis and treatment planning. * When assessing patients with psychosis, it is imperative to inquire about any harmful commands from hallucinations or delusions that may endanger their safety and well-being. * Treatment strategies for major depressive disorder with psychotic features typically involve a combination of antidepressants and antipsychotics, with ECT being an effective but less commonly utilized option. * Continuing antidepressant and antipsychotic treatment for at least four to six months post-remission is essential to prevent rebound psychosis and ensure sustained recovery. * The complexities of prescribing for major depressive disorder with psychotic features necessitate an individualized approach, considering both evidence-based guidelines and patient preferences. Companies mentioned in this episode: * Patreon * Zyprexa * Seroquel * Zoloft * Prozac * Symbiax * Abilify This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

2. juni 202619 min